FDA NDC Directory · JSON-LD · Markdown

Mycapssa

NDC 10122-550 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic nameOctreotide
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208232
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsOCTREOTIDE (20 mg/1)
Marketing started20200706
Package count1

External sources

Source: openFDA. Public-domain (CC0).